Literature DB >> 18007013

Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients.

Zhao-Yan Jiang1, Paolo Parini, Gösta Eggertsen, Matthew A Davis, Hai Hu, Guang-Jun Suo, Sheng-Dao Zhang, Lawrence L Rudel, Tian-Quan Han, Curt Einarsson.   

Abstract

Cholesterol supersaturation of bile is one prerequisite for gallstone formation. In the present study of Chinese patients with gallstones, we investigated whether this phenomenon was correlated with the hepatic expression of genes participating in the metabolism of cholesterol and bile acids. Twenty-two nonobese, normolipidemic patients (female-male, 11:11) with gallstones were investigated with 13 age- and body mass index-matched gallstone-free controls (female-male, 10:3). The bile from the gallstone patients had higher cholesterol saturation than that from the controls. The mRNA levels of ABCG5, ABCG8, and liver X receptor alpha (LXRalpha) in the gallstone patients were increased by 51, 59, and 102%, respectively, and significantly correlated with the molar percentage of biliary cholesterol and cholesterol saturation index (CSI). The mRNA and protein levels of the hepatic scavenger receptor class B type I (SR-BI) were increased, and a significant correlation was found between the protein levels and the CSI. No differences were recorded between the two groups concerning the hepatic synthesis of cholesterol, bile acids, and esterification of cholesterol. Our results suggest that the upregulation of ABCG5/ABCG8 in gallstone patients, possibly mediated by increased LXRalpha, may contribute to the cholesterol supersaturation of bile. Our data are consistent with the possibility that increased amounts of biliary cholesterol may originate from plasma HDL cholesterol by enhanced transfer via SR-BI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18007013     DOI: 10.1194/jlr.M700295-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  30 in total

Review 1.  ABCG5/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-analysis.

Authors:  Lily Jakulj; Maud N Vissers; Michael W T Tanck; Barbara A Hutten; Frans Stellaard; John J P Kastelein; Geesje M Dallinga-Thie
Journal:  J Lipid Res       Date:  2010-06-25       Impact factor: 5.922

Review 2.  An update on the pathogenesis of cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q-H Wang; Piero Portincasa
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

Review 3.  Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.

Authors:  Helen H Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Serum Plant Sterols Associate with Gallstone Disease Independent of Weight Loss and Non-Alcoholic Fatty Liver Disease.

Authors:  Pirjo Käkelä; Ville Männistö; Imre Ilves; Maija Vaittinen; Milla-Maria Tauriainen; Matti Eskelinen; Helena Gylling; Hannu Paajanen; Jussi Pihlajamäki
Journal:  Obes Surg       Date:  2017-05       Impact factor: 4.129

5.  HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver.

Authors:  Camilla Pramfalk; Zhao-Yan Jiang; Qu Cai; Hai Hu; Sheng-Dao Zhang; Tian-Quan Han; Mats Eriksson; Paolo Parini
Journal:  J Lipid Res       Date:  2010-06       Impact factor: 5.922

Review 6.  Biliary cholesterol secretion: more than a simple ABC.

Authors:  Arne Dikkers; Uwe-Jf Tietge
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

7.  Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients.

Authors:  Jorge Herrera; Ludwig Amigo; Constanze Husche; Carlos Benítez; Silvana Zanlungo; Dieter Lütjohann; Juan Francisco Miquel; Flavio Nervi
Journal:  Lipids Health Dis       Date:  2009-12-08       Impact factor: 3.876

8.  Decreased NPC1L1 expression in the liver from Chinese female gallstone patients.

Authors:  Wei Cui; Zhao-Yan Jiang; Qu Cai; Ru-Yuan Zhang; Wei-Ze Wu; Jian-Cheng Wang; Jian Fei; Sheng-Dao Zhang; Tian-Quan Han
Journal:  Lipids Health Dis       Date:  2010-02-08       Impact factor: 3.876

9.  Hepatic insulin resistance directly promotes formation of cholesterol gallstones.

Authors:  Sudha B Biddinger; Joel T Haas; Bian B Yu; Olivier Bezy; Enxuan Jing; Wenwei Zhang; Terry G Unterman; Martin C Carey; C Ronald Kahn
Journal:  Nat Med       Date:  2008-06-29       Impact factor: 53.440

10.  Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Sang Bong Ahn; Kiseok Jang; Dae Won Jun; Byung Hoon Lee; Kye Jung Shin
Journal:  Dig Dis Sci       Date:  2014-08-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.